Cardiac Arrythmias
0
Pipeline Programs
3
Companies
3
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
AbbottABBOTT PARK, IL
2 programsAbbott, Inc Confirm Rx™ versus Medtronic, Inc Reveal LINQTMN/A
Transseptal procedure with Agilis RF TSP System.N/A1 trial
Active Trials
Sparrow PharmaceuticalsOR - Portland
1 programAbbott, Inc Confirm Rx™ versus Medtronic, Inc Reveal LINQTMN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
AbbottTransseptal procedure with Agilis RF TSP System.
Sparrow PharmaceuticalsAbbott, Inc Confirm Rx™ versus Medtronic, Inc Reveal LINQTM
Boston ScientificRhythmia Mapping System
Clinical Trials (3)
Total enrollment: 369 patients across 3 trials
Agilis RF TSP Early Feasibility Study
Start: Feb 2026Est. completion: Aug 202660 patients
N/ARecruiting
Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study
Start: May 2018Est. completion: Mar 2020209 patients
N/ACompleted
RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
Start: May 2016Est. completion: Dec 2027100 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 369 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.